Medical News

RSS

Democrats scale back 'doc fix,' COBRA subsidy in jobs bill

Without congressional action this week on a tax "extenders" and jobs bill, a number of benefits, including a subsidy for COBRA health insurance benefits for newly laid-off workers, will expire.

28 May 2010

Applied Biocode receives CE Certified marking for BioCode-1000 Analyzer

Applied BioCode, Inc. announced that its BioCode-1000 Analyzer has been CE Certified under the compliance of Laboratory Equipment Standards EN55011, EN61010-1, EN61326-1, IEC61010, EN61000-3-2, and EN61000-3-3. The CE Certified marking that the BioCode-1000 Analyzer has met all relevant European Union consumer safety requirements.

28 May 2010

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

In a recent study presented at the American Association of Cancer Research Annual Meeting in Washington, DC, researchers at the University of Texas MD Anderson Cancer Center showed that Positron Emission Mammography (PEM) helps evaluate response to neoadjuvant chemotherapy.

28 May 2010

Hospitalists help coordinate care, reduce hospital costs

The New York Times reports on hospitalists, members of "America's fastest-growing medical specialty. Over a decade, this breed of physician-administrator has increasingly taken over the care of the hospitalized patient.

28 May 2010

UnitedHealth plan to boost dividends may draw criticism

The Associated Press: UnitedHealth Group has drastically raised dividends paid to shareholders - from $35 million to $560 million a year - in a move that may draw criticism for profits that rose alongside soaring health costs. "There is somewhat of a risk, especially in the current fragile reform environment, that says, 'Why is UnitedHealth declaring a dividend instead of lowering health care costs for its members?'" said analyst Tom Carroll.

28 May 2010

ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from GeoVax, Inc.

28 May 2010

Zargis Medical launches live-streaming version of Telemed platform at ATA

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it launched the live-streaming version of its ZargisTelemed™ platform at last week's American Telemedicine Association Conference (ATA) in San Antonio, TX. The system allows healthcare professionals to share stethoscope sounds in real-time with colleagues located anywhere in the world through the Internet or a private network. This technology is cleared for sale in the U.S. and 36 other countries.

28 May 2010

HIV positive acrobat may have affected hundreds nationwide

HIV infected acrobat, 32 year old Godfrey Zaburoni allegedly infected hundreds of women all over Australia and a special task force will help track down all of these women.

27 May 2010

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

CompuMed, Inc., a telemedicine and medical informatics company, reported its CardioGram® and OsteoGram® systems have been incorporated as core components of Visio Mobile Diagnostics' suite of telemedicine and digital x-ray-based healthcare services.

27 May 2010

HeartMate II left ventricular assist device also improves right side heart function

A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart, according to researchers at Henry Ford Hospital's Heart and Vascular Institute.

27 May 2010

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.

27 May 2010

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

For the second consecutive year, The Gestion de Negocios named Welch Allyn, a leading global manufacturer of frontline medical products and solutions, to its list of "The Best Companies to Work For" in Mexico, the country's most comprehensive study of workplace culture. This year's ranking represented a leap of 42 spots, as the company moved from #77 in 2009 to #35 this year—a significant accomplishment for the Welch Allyn de Mexico factory that has only been in operation since 2006.

27 May 2010

TSO3 ships first new 3M Optreoz 125-Z sterilizer with STERIZONE Technology

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, announces the shipment of the first new 3M(TM) Optreoz(TM) 125-Z sterilizer with TSO3 STERIZONE(R) Technology.

27 May 2010

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to further extend the maturity date of Emisphere's Convertible Promissory Note to June 4, 2010.

27 May 2010

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

Bio-Reference Laboratories, Inc. (Numbers in Thousands Except Per Share Data or where otherwise noted) released its second quarter, fiscal year 2010 earnings today for the three months ending April 30. The Company recorded current quarter revenues of $110,447, the best ever quarter in corporate history and an increase of 27% over the $87,183 recorded in the second quarter, fiscal year 2009.

27 May 2010

NOXXON Pharma closes €33 million Series D round of financing

NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.

27 May 2010

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

An active charity supporter has been nominated for Breast Cancer Campaign's 'Fundraiser of the Year' award after raising more than £7,500 to help the charity continue funding vital breast cancer research.

27 May 2010

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants - at least certain kinds - be another risk factor among men and women who engage in receptive anal intercourse? Two studies presented today at the International Microbicides Conference in Pittsburgh, suggest the answer is yes.

27 May 2010

Scientists develop inexpensive method for determining chemicals that may cause skin allergies

Scientists are reporting development of a fast, simple, inexpensive method for determining whether chemicals in consumer products and workplaces may cause skin allergies in people -- a method that does not involve use of animals. Their study appears in ACS' Chemical Research in Toxicology, a monthly journal.

27 May 2010

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat serious acute cardiovascular disorders and infectious diseases, has received a grant in the amount of $150,000 from the National Science Foundation to support the development of antimicrobial sutures. PolyMedix has developed a series of novel antimicrobial polymers for device and material applications, which it collectively calls the PolyCides™.

27 May 2010

Medical News

Democrats scale back 'doc fix,' COBRA subsidy in jobs bill

Applied Biocode receives CE Certified marking for BioCode-1000 Analyzer

Positron Emission Mammography helps evaluate response to neoadjuvant chemotherapy: Study

Hospitalists help coordinate care, reduce hospital costs

UnitedHealth plan to boost dividends may draw criticism

ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine

Zargis Medical launches live-streaming version of Telemed platform at ATA

HIV positive acrobat may have affected hundreds nationwide

CompuMed's digital telemedicine technologies incorporated in Visio Mobile Diagnostics' healthcare services suite

HeartMate II left ventricular assist device also improves right side heart function

St. Jude Medical's Epiducer lead delivery system for neurostimulation therapy receives CE Mark approval

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

TSO3 ships first new 3M Optreoz 125-Z sterilizer with STERIZONE Technology

Emisphere Technologies announces further extension of Convertible Promissory Note maturity date

Bio-Reference Laboratories second-quarter revenues up 27% to $110,447,000

NOXXON Pharma closes €33 million Series D round of financing

Active charity supporter nominated for Breast Cancer Campaign's Fundraiser of the Year award

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

Scientists develop inexpensive method for determining chemicals that may cause skin allergies

National Science Foundation supports PolyMedix with $150,000 grant for development of antimicrobial sutures

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News